MS Pharma has sponsored and participated in the “MENA Biosimilars training” that was done in Amman on the 22nd and 23rd of September 2018, and supported by the “Jordan Food and Drug Administration”. The training included a lot of scientific sessions and discussions about this important topic presented by experts from different countries.

MS Pharma team also presented a case study about “Biosimilars Access Barriers and Solutions in Jordan”.

Such training is very crucial since the future of the pharmaceutical industry is moving towards the biosimilar products, and it is important to exchange experiences with people from different fields of expertise.